Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2024-05-09 00:00:00 ET · period of report 2024-05-07 · accession 0000950170-24-056947 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-09 | 2024-05-07 | FULC | Tourangeau Greg | Principal Accounting Off | S - Sale | $7.76 | -236 | 11.6K | -2% | -$1,831 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-07 | S | D | 236 | $7.76 | 11,571 | D | — | — |